Performance measurement in chronic kidney disease

Journal of the American Society of Nephrology

Volumn 22, Issue 2, 2011, Pages 225-234

  Smith, Kimberly A ^a   Hayward, Rodney A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; KIDNEY FAILURE; OUTCOME ASSESSMENT; PERFORMANCE MEASUREMENT SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 79551660694     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010111152     Document Type: Review

References (115)

1. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA: The quality of health care delivered to adults in the United States. N Engl J Med 348: 2635-2645, 2003
2. Kerr EA, McGlynn EA, Adams J, Keesey J, Asch SM: Profiling the quality of care in twelve communities: Results from the CQI study. Health Aff (Millwood) 23: 247-256, 2004
3. Chassin MR, Galvin RW: The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA 280: 1000-1005, 1998
4. Krumholz HM, Anderson JL, Brooks NH, Fesmire FM, Lambrew CT, Landrum MB, Weaver WD, Whyte J, Bonow RO, Bennett SJ, Burke G, Eagle KA, Linderbaum J, Masoudi FA, Normand SL, Pina IL, Radford MJ, Rumsfeld JS, Ritchie JL, Spertus JA: ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation 113: 732-761, 2006
5. Lee TH: Eulogy for a quality measure. N Engl J Med 357: 1175-1177, 2007
6. Chassin MR, Loeb JM, Schmaltz SP, Wachter RM: Accountability measures- using measurement to promote quality improvement. N Engl J Med 363: 683-688, 2010
7. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA: The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24: 1815-1820, 2001
8. Kerr E: Assessing Quality of Care for Diabetes: Conference Final Report. AHRQ Publication No. 08-0037-EF, Rockville, MD, Agency for Healthcare Research and Quality, 2008
9. Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC: Chronic kidney disease adversely influences patient safety. J Am Soc Nephrol 19: 2414-2419, 2008
10. Blue Cross Blue Shield of Michigan: Physician Group Incentive Program Chronic Kidney Disease Initiative. Available at: http://www.bcbsm.com/provider/ value-partnerships/pgip/chronic-kidney-disease.shtml. Accessed October 26, 2010
11. QIO Synergy. Available at: http://www.qiosynergy.org/default.aspx?ID=ckd. Accessed October 26, 2010
12. The Joint Commission Chronic Kidney Disease Certification. Available at: http://www.jointcommission.org/certification/chronic-kidney-disease.aspx. Accessed October 26, 2010
13. Himmelfarb J, Kliger AS: End-stage renal disease measures of quality. Annu Rev Med 58: 387-399, 2007 (Pubitemid 46706522)
14. Wish JB: Quality and accountability in the ESRD program. Adv Ren Replace Ther 8: 89-94, 2001
15. Desai AA, Garber AM, Chertow GM: Rise of pay for performance: Implications for care of people with chronic kidney disease. Clin J Am Soc Nephrol 2: 1087-1095, 2007
16. Himmelfarb J, Pereira BJ, Wesson DE, Smedberg PC, Henrich WL: Payment for quality in end-stage renal disease. J Am Soc Nephrol 15: 3263-3269, 2004 (Pubitemid 39578860)
17. McClellan WM, Frankenfield DL, Frederick PR, Helgerson SD, Wish JB, Sugarman JR: Improving the care of ESRD patients: A success story. Health Care Financ Rev 24: 89-100, 2003 (Pubitemid 37264939)
18. Foley RN, Hakim RM: Why is the mortality of dialysis patients in the United States much higher than the rest of the world? J Am Soc Nephrol 20: 1432-1435, 2009
19. United States Renal Data System: 2010 Atlas of End-Stage Renal Disease in the United States. Available at: http://www.usrds.org/2010/slides/indiv/ 1v2index.html. Accessed on October 26, 2010
20. Rocco MV, Frankenfield DL, Hopson SD, McClellan WM: Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 145: 512-519, 2006
21. Levin, A: The need for optimal and coordinated management of CKD. Kidney Int Suppl: S7-S10, 2005
22. Parker TF 3rd, Blantz R, Hostetter T, Himmelfarb J, Kliger A, Lazarus M, Nissenson AR, Pereira B, Weiss J: The chronic kidney disease initiative. J Am Soc Nephrol 15: 708-716, 2004
23. Rettig RA, Norris K, Nissenson AR: Chronic kidney disease in the United States: A public policy imperative. Clin J Am Soc Nephrol 3: 1902-1910, 2008
24. McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV: Treatment center and geographic variability in pre- ESRD care associate with increased mortality. J Am Soc Nephrol 20: 1078-1085, 2009
25. RAND Health: Quality of Care Assessment Tools. Available at: http://www.rand.org/health/surveys-tools/qatools/index.html. Accessed October 26, 2010
26. National Committee for Quality Assurance: HEDIS 2010 Version 2. Available at: http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2010/2010-Measures.pdf. Accessed October 26, 2010
27. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 49: S12-S154, 2007
28. Kimoto E, Shoji T, Shinohara K, Hatsuda S, Mori K, Fukumoto S, Koyama H, Emoto M, Okuno Y, Nishizawa Y: Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease. J Am Soc Nephrol 17: 2245-2252, 2006
29. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43: S1-S290, 2004
30. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1-S201, 2003
31. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
32. Bolton WK: Renal physicians association clinical practice guideline: Appropriate patient preparation for renal replacement therapy: Guideline number 3. J Am Soc Nephrol 14: 1406-1410, 2003
33. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl: S1-S130, 2009
34. Grimshaw JM, Russell IT: Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations. Lancet 342: 1317-1322, 1993
35. Curry SJ: Organizational interventions to encourage guideline implementation. Chest 118: 40S-46S, 2000
36. Hayward RA, Hofer TP, Kerr EA, Krein SL: Quality improvement initiatives: Issues in moving from diabetes guidelines to policy. Diabetes Care 27[Suppl 2]: B54-B60, 2004
37. O'Malley AS, Clancy C, Thompson J, Korabathina R, Meyer GS: Clinical practice guidelines and performance indicators as related-but often misunderstood-tools. Jt Comm J Qual Saf 30: 163-171, 2004
38. Kliger AS, Haley WE: Clinical practice guidelines in end-stage renal disease: A strategy for implementation. J Am Soc Nephrol 10: 872-877, 1999
39. Renal Physicians Association Clinical Performance Measures on Appropriate Patient Preparation for Renal Replacement Therapy. Available at: http://www.qualitymeasures.ahrq.gov/browse/by-organization-indiv.aspx? orgid=23&objid=532. Accessed November 19, 2010,
40. Renal Physician's Association/Physician Consortium for Performance Improvement (PCPI) Chronic Kidney Disease Performance Measures Chronic Kidney Disease Measures. Available at: http://www.ama-assn.org/ama1/pub/upload/mm/370/ ckdws110107.pdf.
41. Kerr EA, Hofer TP, Hayward RA, Adams JL, Hogan MM, McGlynn EA, Asch SM: Quality by any other name?: A comparison of three profiling systems for assessing health care quality. Health Serv Res 42: 2070-2087, 2007
42. Hofer TP, Asch SM, Hayward RA, Rubenstein LV, Hogan MM, Adams J, Kerr EA: Profiling quality of care: Is there a role for peer review? BMC Health Serv Res 4: 9, 2004
43. Mant J: Process versus outcome indicators in the assessment of quality of health care. Int J Qual Health Care 13: 475-480, 2001
44. McGlynn EA, Asch SM: Developing a clinical performance measure. Am J Prev Med 14: 14-21, 1998
45. Donabedian A: The quality of care. How can it be assessed? JAMA 260: 1743-1748, 1988
46. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG: The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA 281: 2098-2105, 1999
47. Mant J, Hicks N: Detecting differences in quality of care: The sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ 311: 793-796, 1995
48. Hofer TP, Hayward RA: Identifying poor-quality hospitals. Can hospital mortality rates detect quality problems for medical diagnoses? Med Care 34: 737-753, 1996
49. Salem-Schatz S, Moore G, Rucker M, Pearson SD: The case for case-mix adjustment in practice profiling. When good apples look bad. JAMA 272: 871-874, 1994 (Pubitemid 24987303)
50. Bernard AM, Hayward RA, Rosevear J, Chun H, McMahon LF: Comparing the hospitalizations of transfer and non-transfer patients in an academic medical center. Acad Med 71: 262-266, 1996 (Pubitemid 26089605)
51. All Patient Refined Diagnosis Related Groups: Methodology Overview. Available at: http://www.hcup-us.ahrq.gov/db/nation/nis/APR- DRGsV20MethodologyOverviewand Bibliography.pdf. Accessed November 16, 2010
52. Blumenthal D, Weissman JS, Wachterman M, Weil E, Stafford RS, Perrin JM, Ferris TG, Kuhlthau K, Kaushal R, Iezzoni LI: The who, what, and why of risk adjustment: A technology on the cusp of adoption. J Health Polit Policy Law 30: 453-473, 2005 (Pubitemid 40911368)
53. Hsu CY: Where is the epidemic in kidney disease? J Am Soc Nephrol 21: 1607-1611, 2010
54. Ikizler TA: CKD classification: Time to move beyond KDOQI. J Am Soc Nephrol 20: 929-930, 2009
55. Bauer C, Melamed ML, Hostetter TH: Staging of chronic kidney disease: Time for a course correction. J Am Soc Nephrol 19: 844-846, 2008
56. Cho K, Hsu CY: Quantifying severity of chronic kidney disease as a risk factor for acute kidney injury. J Am Soc Nephrol 21: 1602-1604, 2010
57. Grams ME, Astor BC, Bash LD, Matsushita K, Wang Y, Coresh J: Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury. J Am Soc Nephrol 21: 1757-1764, 2010
58. Hong CS, Atlas SJ, Chang Y, Subramanian SV, Ashburner JM, Barry MJ, Grant RW: Relationship between patient panel characteristics and primary care physician clinical performance rankings. JAMA 304: 1107-1113, 2010
59. Iezzoni LI: The risks of risk adjustment. JAMA 278: 1600-1607, 1997
60. Fischer MJ, O'Hare AM: Epidemiology of hypertension in the elderly with chronic kidney disease. Adv Chronic Kidney Dis 17: 329-340, 2010
61. Zamboli P, De Nicola L, Minutolo R, Bertino V, Catapano F, Conte G: Management of hypertension in chronic kidney disease. Curr Hypertens Rep 8: 497-501, 2006
62. Timbie JW, Hayward RA, Vijan S: Diminishing efficacy of combination therapy, response-heterogeneity, and treatment intolerance limit the attainability of tight risk factor control in patients with diabetes. Health Serv Res 45: 437-456, 2010
63. Norris K, Nissenson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 19: 1261-1270, 2008
64. Kerr EA, Krein SL, Vijan S, Hofer TP, Hayward RA: Avoiding pitfalls in chronic disease quality measurement: A case for the next generation of technical quality measures. Am J Manag Care 7: 1033-1043, 2001
65. Kerr EA, Smith DM, Hogan MM, Hofer TP, Krein SL, Bermann M, Hayward RA: Building a better quality measure: are some patients with 'poor quality' actually getting good care? Med Care 41: 1173-1182, 2003
66. Lewis EJ: Captopril and diabetic nephropathy. JAMA 273: 1831, 1995
67. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
68. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860, 2001
69. Foley RN: Do we know the correct hemoglobin target for anemic patients with chronic kidney disease? Clin J Am Soc Nephrol 1: 678-684, 2006
70. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006
71. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006
72. Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, Carlisle E, Barre P, Magner P, Muirhead N, Tobe S, Tam P, Wadgymar JA, Kappel J, Holland D, Pichette V, Shoker A, Soltys G, Verrelli M, Singer J: Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 46: 799-811, 2005
73. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50: 471-530, 2007
74. Locatelli F, Nissenson AR, Barrett BJ, Walker RG, Wheeler DC, Eckardt KU, Lameire NH, Eknoyan G: Clinical practice guidelines for anemia in chronic kidney disease: Problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 74: 1237-1240, 2008
75. Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA: Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 363: 1146-1155, 2010
76. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
77. Singh AK: Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol 21: 2-6, 2010
78. Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC: Haemoglobin targets: We were wrong, time to move on. Lancet 369: 346-350, 2007
79. Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Goldfarb S: KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKDMBD). Am J Kidney Dis 55: 773-799, 2010
80. Ketteler M, Gross ML, Ritz, E: Calcification and cardiovascular problems in renal failure. Kidney Int Suppl: S120-S127, 2005
81. Moe SM, Drueke TB: A bridge to improving healthcare outcomes and quality of life. Am J Kidney Dis 43: 552-557, 2004
82. Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W: Adherence to K/DOQI practice guidelines for bone metabolism and disease. Am J Manag Care 13: 620-625, 2007
83. Patwardhan MB, Samsa GP, Matchar DB, Haley WE: Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: A database analysis. Clin J Am Soc Nephrol 2: 277-283, 2007
84. Philipneri MD, Rocca Rey LA, Schnitzler MA, Abbott KC, Brennan DC, Takemoto SK, Buchanan PM, Burroughs TE, Willoughby LM, Lentine KL: Delivery patterns of recommended chronic kidney disease care in clinical practice: Administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 12: 41-52, 2008
85. Lewis JB: Blood pressure control in chronic kidney disease: Is less really more? J Am Soc Nephrol 21: 1086-1092, 2010
86. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330: 877-884, 1994
87. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ: Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144: 884-893, 2006
88. Choe HM, Bernstein SJ, Standiford CJ, Hayward RA: New diabetes HEDIS blood pressure quality measure: Potential for overtreatment. Am J Manag Care 16: 19-24, 2010
89. Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD: Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol 20: 2641-2650, 2009
90. Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP: Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: A randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol 18: 1889-1898, 2007
91. Hurst FP, Abbott KC, Raj D, Krishnan M, Palant CE, Agodoa LY, Jindal RM: Arteriovenous fistulas among incident hemodialysis patients in Department of Defense and Veterans Affairs facilities. J Am Soc Nephrol 21: 1571-1577, 2010
92. Schwab SJ, Brown KD: Immature public policy for vascular access. J Am Soc Nephrol 21: 1420-1421, 2010
93. Santoro A, Canova C, Freyrie A, Mancini E: Vascular access for hemodialysis. J Nephrol 19: 259-264, 2006
94. Fistula First. Available at: http://www.fistulafirst.org/. Accessed on December 8, 2010
95. Glassock RJ, Winearls C: Diagnosing chronic kidney disease. Curr Opin Nephrol Hypertens 19: 123-128, 2010
96. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP: Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 20: 1199-1209, 2009
97. Zulman DM, Vijan S, Omenn GS, Hayward RA: The relative merits of population-based and targeted prevention strategies. Milbank Q 86: 557-580, 2008
98. Hayward RA, Krumholz HM, Zulman DM, Timbie JW, Vijan S: Optimizing statin treatment for primary prevention of coronary artery disease. Ann Intern Med 152: 69-77, 2010
99. Patel UD, Young EW, Ojo AO, Hayward RA: CKD progression and mortality among older patients with diabetes. Am J Kidney Dis 46: 406-414, 2005
100. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
101. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR: Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 20: 1069-1077, 2009
102. Shahinian VB, Saran R: The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis 17: 246-253, 2010
103. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 294: 716-724, 2005
104. Agrawal V, Ghosh AK, Barnes MA, McCullough PA: Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: A national online survey. Am J Kidney Dis 52: 1061-1069, 2008
105. Charles RF, Powe NR, Jaar BG, Troll MU, Parekh RS, Boulware LE: Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. Am J Kidney Dis 54: 227-237, 2009
106. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM: Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20: 2075-2084, 2009
107. Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, McMahon DJ, Leonard MB, Shane E: Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol 21: 1371-1380, 2010
108. Hofer TP, Zemencuk JK, Hayward RA: When there is too much to do: How practicing physicians prioritize among recommended interventions. J Gen Intern Med 19: 646-653, 2004
109. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL: Primary care: Is there enough time for prevention? Am J Public Health 93: 635-641, 2003
110. McGlynn EA: Six challenges in measuring the quality of health care. Health Aff (Millwood) 16: 7-21, 1997
111. Hayward RA: Access to clinically-detailed patient information: A fundamental element for improving the efficiency and quality of healthcare. Med Care 46: 229-231, 2008
112. Patterson ME, Hernandez AF, Hammill BG, Fonarow GC, Peterson ED, Schulman KA, Curtis LH: Process of care performance measures and long-term outcomes in patients hospitalized with heart failure. Med Care 48: 210-216, 2010
113. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy C, Young JB: Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 297: 61-70, 2007
114. Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM: Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 303: 2479-2485, 2010
115. Landon BE, Hicks LS, O'Malley AJ, Lieu TA, Keegan T, McNeil BJ, Guadagnoli E: Improving the management of chronic disease at community health centers. N Engl J Med 356: 921-934, 2007